INTANGIBLE ASSETS, NET

12 Months Ended

Mar. 31, 2012

INTANGIBLE ASSETS, NET [Abstract]

INTANGIBLE ASSETS, NET

NOTE 7.  INTANGIBLE ASSETS, NET

Intangible assets, net, at March 31, 2012 and 2011 consisted of the following (in thousands):

			Accumulated		Net Book
	Cost		Amortization		Value
Balance, March 31, 2012
Licenses	$	5,000	$	1,625		3,375
Patents		750		675		75
Other		637		97		540
Total intangible assets	$	6,387	$	2,397	$	3,990
Balance, March 31, 2011
Licenses	$	5,000	$	1,125	$	3,875
Patents		750		600		150
Other		249		58		191
Total intangible assets	$	5,999	$	1,783	$	4,216

In January 2009, we entered into a license agreement with Inverness Medical Switzerland GmbH, now known as Alere Switzerland GmbH ("Alere"), pursuant to which we licensed co-exclusively certain worldwide patent rights.  We paid a $5.0 million up-front license fee to Alere in January 2009, which was recorded as an intangible asset on the consolidated balance sheets.  See Note 10, "Commitments and Contingencies" for additional information on our patent license agreement with Alere.

Other intangible assets, with a cost basis of $249,000 and $388,000, were acquired by issuing warrants to National Institute for Strategic Technology Acquisition and Commercialization in January 2011 and October 2011, respectively.

Amortization expense for intangible assets, included in cost of revenues or in the respective operating expense line based on the function and purpose for which it is being used, amounted to $614,000, $633,000 and $575,000 in fiscal 2012, 2011 and 2010, respectively.  Based on our intangible assets subject to amortization as of March 31, 2012, the estimated amortization expense for succeeding years is as follows (in thousands):

	Estimated Future Annual Amortization Expense
			Fiscal Year Ending March 31,
	Total		2013		2014		2015		2016		2017		Thereafter
Amortization expense	$	3,990	$	634	$	558	$	558	$	558	$	558	$	1,124